Free Newsletter
Assay speeds contaminant hunt
The Millipore/Roka Bioscience collaboration reported earlier is bearing additional fruit: A tool for early detection of mycoplasma contamination in bioprocessing. The partners have an assay for Pseudomonas aeruginosa on the market already.
Millipore says that the MilliPROBE Detection System for Mycoplasma cuts to four hours the traditional culture-based detection time of 28 to 35 days. The assay builds on the company's mycoplasma risk management efforts and integrates sample-preparation and testing technologies with molecular diagnostics technologies from Roka.
The difficult-to-eliminate mycoplasma is a self-replicating bacterium that invades biopharmaceutical manufacturing processes, the company says. Its presence can lead to batch destruction and even facility shutdown for decontamination.
The alliance has plans to develop detection techniques for additional bioprocess contaminants and to commercialize assays.
- here's the Millipore announcement
Related Articles:
Quality shift pays off for Millipore
Tools speed contaminant detection
Deal adds drug analysis to Millipore offerings
Disposable bioreactor boasts impeller stirring
Millipore expands in Massachusetts
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession





SHARE
WITH: